ClinicalTrials.govpublic full text
DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
hematopoietic and lymphoid cell neoplasm, recurrent acute lymphoblastic leukemia, recurrent acute myeloid leukemia, recurrent chronic myelomonocytic leukemia, recurrent myelodysplastic syndrome, refractory acute lymphoblastic leukemia, refractory acute myeloid leukemia, refractory chronic myelomonocytic leukemia, refractory myelodysplastic syndrome, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 813123
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.